TY - JOUR
KW - Adolescent
KW - Adult
KW - Delayed-Action Preparations
KW - Double-Blind Method
KW - Female
KW - Humans
KW - Long-acting injectable naltrexone
KW - Male
KW - Middle Aged
KW - Naltrexone/administration & dosage/therapeutic use
KW - Narcotic Antagonists/administration & dosage/therapeutic use
KW - opiate dependence
KW - Opioid antagonist
KW - Opioid-Related Disorders/drug therapy
KW - Patient Dropouts/statistics & numerical data
KW - Proportional Hazards Models
KW - treatment retention
KW - Urine toxicology
AU - M. A. Sullivan
AU - A. Bisaga
AU - J. J. Mariani
AU - A. Glass
AU - F. R. Levin
AU - S. D. Comer
AU - E. V. Nunes
A1 - 
BT - Drug and alcohol dependence
C5 - Opioids & Substance Use
CP - 1
CY - Ireland
DO - 10.1016/j.drugalcdep.2013.05.030
IS - 1
JF - Drug and alcohol dependence
PB - Elsevier Ireland Ltd
PP - Ireland
PY - 2013
SN - 1879-0046; 0376-8716
SP - 80
EP - 85
EP - 
T1 - Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?
T2 - Drug and alcohol dependence
TI - Naltrexone treatment for opioid dependence: does its effectiveness depend on testing the blockade?
U1 - Opioids & Substance Use
U2 - 23827259
U3 - 10.1016/j.drugalcdep.2013.05.030
VL - 133
VO - 1879-0046; 0376-8716
Y1 - 2013
ER -